Log in to save to my catalogue

Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug...

Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ab3c6d6c3d14f348a694c99267844c7

Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience

About this item

Full title

Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience

Publisher

Japan: John Wiley & Sons, Inc

Journal title

Journal of arrhythmia, 2023-10, Vol.39 (5), p.784-789

Language

English

Formats

Publication information

Publisher

Japan: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Real-world clinical data on the adverse events related to the use of cryoballoon catheter for pulmonary vein isolation remains limited.
To report and describe the adverse events related to the use of Artic Front cryoballoon catheters (Arctic Front, Arctic Front Advance, and Arctic Front Advance Pro) reported in the Food and Drug Administration's...

Alternative Titles

Full title

Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9ab3c6d6c3d14f348a694c99267844c7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ab3c6d6c3d14f348a694c99267844c7

Other Identifiers

ISSN

1880-4276

E-ISSN

1883-2148

DOI

10.1002/joa3.12898

How to access this item